These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8094981)

  • 1. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
    Ramirez B; Richter JE
    Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current status of gastric prokinetic drugs.
    Schapira M; Henrion J; Heller FR
    Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cisapride on symptoms and healing of gastro-oesophageal reflux disease: a review.
    Richter JE
    Scand J Gastroenterol Suppl; 1989; 165():19-27; discussion 27-8. PubMed ID: 2690321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
    McCallum RW
    Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
    Hatlebakk JG; Berstad A
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokinetic therapy in gastroesophageal reflux disease.
    Champion MC
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Megens AA; Awouters FH; Niemegeers CJ
    Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical therapy of reflux oesophagitis.
    Tytgat GN; Nio CY
    Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of gastroduodenal coordination: dopaminergic and cholinergic pathways.
    Schuurkes JA; Van Nueten JM
    Scand J Gastroenterol Suppl; 1984; 92():8-12. PubMed ID: 6146199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisapride for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S
    Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
    Wienbeck M; Li Q
    Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
    Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
    Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.